Abstract
The REST-IT study found the addition of zolpidem-controlled release (CR) provided a significant reduction in observer-rated measurement of suicidal ideation (the Columbia Suicide Severity Rating Scale) in 103 depressed outpatients with insomnia and suicidal ideation, but without significant change in a self-report measure of suicidal ideation (the Scale for Suicide Ideation). This secondary analysis of the REST-IT data examined the suicide item of another observer-rated scale, the Hamilton Rating Scale for Depression (HRSD), further clarifying the impact of insomnia-focused treatment on suicidal ideation. This analysis established a significant advantage for zolpidem-CR compared with placebo on the HRSD suicide item.
Original language | English (US) |
---|---|
Article number | 115576 |
Journal | Psychiatry Research |
Volume | 330 |
DOIs | |
State | Published - Dec 2023 |
Keywords
- Hypnotic
- Observer-rated
- Self-report
ASJC Scopus subject areas
- Psychiatry and Mental health
- Biological Psychiatry